市場調查報告書
商品編碼
1396537
臨床試驗供應和物流市場 - 按服務類型(物流和配送)、階段(第一階段、第二階段)、治療領域(腫瘤學、眼科)、最終用途、全球預測,2023 - 2032 年Clinical Trial Supply & Logistics Market - By Service Type (Logistics & Distribution), Phase (Phase I, Phase II), Therapeutic Area (Oncology, Ophthalmology), End-use, Global Forecast, 2023 - 2032 |
在全球生物製藥產業不斷擴大的推動下,臨床試驗供應和物流市場規模預計從 2023 年到 2032 年將以 7.9% 的CAGR擴大。藥物開發(特別是生物製劑和特種藥物)的持續創新正在擴大生物製藥領域對專業供應和物流服務的需求。生物製藥產品的複雜性進一步需要客製化的儲存、處理和運輸解決方案。
隨著人們越來越關注透過複雜的製造流程推進療法,一些製藥公司、合約研究組織(CRO) 和物流提供者正在建立合作夥伴關係,以提高臨床試驗供應鏈的效率和可靠性,進一步推動產業前景。 2023 年 6 月,藥品溫控提供者 SkyCell 與 Marken 攜手,為臨床試驗藥品提供升級的運送選項。
臨床試驗供應和物流行業分為服務類型、階段、治療領域、最終用途和區域。
就服務類型而言,預計2023-2032年藥品製造領域的市佔率複合CAGR為5.7%。製藥公司不斷努力為新藥開發進行廣泛的臨床試驗,這增加了對高效、可靠的供應鏈解決方案的需求。人們日益關注維持監管合規性和最大限度地降低成本,以及確保研究藥物從生產設施及時安全地交付到臨床試驗場所的專業服務的可用性不斷增加,預計將推動該細分市場的成長。
根據最終用途,到 2032 年,醫療器材公司領域的臨床試驗供應和物流市場預計將以 6.3% 的成長率成長。隨著多家醫療器材公司參與廣泛的臨床試驗,將創新產品推向市場,需求高效率、專業的供應鏈解決方案的需求量顯著上升。此外,人們越來越傾向於客製化服務,以確保及時、安全地將研究醫療設備交付到臨床試驗地點,預計將推動該細分市場的成長。
從地區來看,歐洲臨床試驗供應和物流行業在 2022 年佔據了相當大的收入佔有率,在蓬勃發展的製藥和生物技術行業的推動下,2023 年至 2032 年期間將呈現 7.8% 的成長率。由於擁有完善的基礎設施、監管架構和經驗豐富的臨床研究環境,歐洲已成為全球臨床試驗的重要中心,進一步增加了對專業供應鏈和物流服務的需求。
一些產業參與者也為醫療保健組織提供更簡化的解決方案,以解決新藥開發不斷增加所帶來的物流問題。例如,2023年10月,UPS Healthcare在英國、法國、義大利、德國和西班牙推出了UPS Pickup Point站點,為健康實驗室客戶提供新的逆向物流服務。
Clinical Trial Supply & Logistics Market size is projected to expand at 7.9% CAGR from 2023-2032 driven by the expanding biopharmaceutical sector worldwide. The continuous innovations in drug development, particularly biologics and specialty drugs, is amplifying the demand for specialized supply and logistics services across the biopharma domain. The intricate nature of biopharmaceutical products is further necessitating tailored solutions for storage, handling, and transportation.
With the surging focus on advancing therapies with complex manufacturing processes, several pharmaceutical companies, contract research organizations (CROs), and logistics providers are entering partnerships to enhance the efficiency and reliability of clinical trial supply chains, further propelling the industry outlook. In June 2023, pharma temperature-controlled provider SkyCell joined hands with Marken to deliver upgraded transportation options for clinical trials pharmaceutical goods.
The clinical trial supply & logistics industry is segmented into service type, phase, therapeutic area, end-use, and region.
In terms of service type, the market share from the drug manufacturing segment is anticipated to depict 5.7% CAGR from 2023-2032. The ongoing efforts by pharmaceutical companies to conduct extensive clinical trials for the development of new drugs is surging the demand for efficient and reliable supply chain solutions. The rising focus on maintaining regulatory compliance and minimizing costs along with the increasing availability of specialized services for ensuring timely and secure delivery of investigational drugs from manufacturing facilities to clinical trial sites is expected to propel segment growth.
Based on end-use, the clinical trial supply & logistics market from the medical device companies segment is expected to depict 6.3% growth rate through 2032. With several medical device companies engaging in extensive clinical trials to bring innovative products to the market, the demand for efficient and specialized supply chain solutions is significantly rising. Additionally, the increasing preference for tailored services to ensure the timely and secure delivery of investigational medical devices to clinical trial sites is anticipated to fuel the segment growth.
Regionally, the Europe clinical trial supply and logistics industry held sizable revenue share in 2022 and is set to exhibit 7.8% growth rate between 2023 and 2032 propelled by the thriving pharmaceutical and biotechnology sectors. Europe has emerged as a prominent hub for global clinical trials owing to the presence of an established infrastructure, regulatory frameworks, and experienced clinical research landscape, further surging the demand for specialized supply chain and logistics services.
Several industry participants are also offering more streamlined solutions to healthcare organizations to address the logistic issues propelled by the increased development of new medicines. For instance, in October 2023, UPS Healthcare launched UPS Pickup Point sites in the U.K., France, Italy, Germany, and Spain to provide a new reverse logistics service for health laboratory clients.